Cargando…
Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
OBJECTIVE: To assess the feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya. BACKGROUND: HIV prevention trials require the inclusion of those at high risk of HIV infection and their informed decision to take part and remain in the clinical trial to the end is cru...
Autores principales: | Mutisya, Elizabeth Mueni, Muturi-Kioi, Vincent, Abaasa, Andrew, Nyasani, Delvin, Kabuti, Rhoda W., Lunani, Laura, Kotikot, Timothy, Mundia, Moses, Mutua, Gaudensia, Ombati, Geoffrey, Nduta, Hannah, Price, Matt A., Kimani, Joshua, Anzala, Aggrey Omu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762985/ https://www.ncbi.nlm.nih.gov/pubmed/36536335 http://dx.doi.org/10.1186/s12889-022-14875-2 |
Ejemplares similares
-
Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020) -
Sexually transmitted infection knowledge among men who have sex with men in Nairobi, Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2023) -
Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017) -
Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018) -
Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)